Alpine Woods Capital Investors, LLC Cara Therapeutics, Inc. Transaction History

Alpine Woods Capital Investors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$8.24 - $12.56 $9,986 - $15,222	-1,212 Reduced 0.7%	171,423 $1.61 Million
Q2 2022 Aug 02, 2022	SELL	$7.45 - $13.84 $2,823 - $5,245	-379 Reduced 0.22%	172,635 $1.58 Million
Q1 2022 May 10, 2022	BUY	$9.94 - $12.65 $298 - $379	30 Added 0.02%	173,014 $2.1 Million
Q4 2021 Feb 03, 2022	SELL	$11.99 - $18.14 $139,659 - $211,294	-11,648 Reduced 6.31%	172,984 $2.11 Million
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $1.56 Million - $2.17 Million	135,200 Added 273.51%	184,632 $2.85 Million
Q2 2021 Aug 09, 2021	SELL	$12.38 - $29.19 $140,834 - $332,065	-11,376 Reduced 18.71%	49,432 $705,000
Q1 2021 May 11, 2021	BUY	$15.07 - $21.71 $43,416 - $62,546	2,881 Added 4.97%	60,808 $1.32 Million
Q4 2020 Feb 01, 2021	BUY	$12.72 - $16.16 $504,831 - $641,358	39,688 Added 217.6%	57,927 $876,000
Q3 2020 Nov 02, 2020	BUY	$12.34 - $17.92 $225,069 - $326,842	18,239 New	18,239 $232,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.